Ikris Pharma Network

Named Patient Program

Compliant Access to Unapproved Medicines: We ensure 100% regulatory-compliant supply of hard-to-access medicines in India and emerging markets. Supporting Global Patient Assistance Programs (PAPs): Partnering with global innovators, we enable access to transformative therapies in oncology and rare diseases. Reference Listed Drugs (RLDs): Supplying comparator drugs for clinical trials and bioequivalence studies. Rare Disease Medicines: Providing ethical access where treatment choices are limited.

Our Standards: Product Authenticity: Every shipment comes directly from licensed manufacturers or their authorized distributors. Regulatory Oversight: Fully compliant with CDSCO regulations, DGFT import permits, and WHO-GDP standards. Global Warehousing: EU-GDP certified warehouses in Belgium and Bulgaria for fully compliant storage and cold-chain logistics. Our Promise: We collaborate with healthcare professionals, hospitals, NGOs, and government tenders to ensure patients receive trusted therapies on time. With transparency, compliance, and patient-first care, we continue to be at the forefront of Named Patient Programs, RLD Supply, and Rare Disease Access worldwide